UCP2 and ovarian cancer: Relatively high mutation rates were also observed in ovarian cancer cell lines for SLC25A13, SLC25A24, SLC25A41, and SLC25A23 and in skin cancer cell lines for SLC25A13, SLC25A8, and SLC25A12.